Literature DB >> 27136416

Aberrant resting-state functional connectivity in limbic and cognitive control networks relates to depressive rumination and mindfulness: A pilot study among adolescents with a history of depression.

Amy T Peters1, Katie Burkhouse2, Claudia C Feldhaus1, Scott A Langenecker1, Rachel H Jacobs3.   

Abstract

BACKGROUND: Resting state functional connectivity (RSFC) research among adults indicates abnormalities within and between neural networks during acute depressive episodes, some of which are likely to remain into remission. The examination of RSFC among adolescents within the remitted state of MDD may implicate markers of illness course during a critical developmental window wherein secondary prevention can be implemented.
METHODS: RSFC data were collected on a 3.0T GE scanner from adolescents (12-18, M=15.61, SD=1.90; 57% female) in full or partial remission from MDD (rMDD; n=23) and age- and gender-matched healthy controls (HC; n=10). RSFC data were examined using seed-based connectivity of the left amygdala, left dorsolateral prefrontal cortex (dlPFC), and left posterior cingulate cortex (PCC). These seeds were chosen to probe the emotional salience, cognitive control, and default mode networks, respectively.
RESULTS: rMDD adolescents demonstrated relative hyperconnectivity from the left amygdala to the right PCC, as well as from the left dlPFC to the right middle frontal and left inferior frontal gyri (MFG, IFG). Amygdala to PCC connectivity was correlated with greater rumination, dlPFC to MFG connectivity was positively associated with depression severity, and dlPFC to IFG connectivity was inversely associated with mindfulness.
CONCLUSIONS: Aberrant functional connectivity within and between neural networks responsible for salience attribution, introspective thought, and executive control can be observed among adolescents in the remitted phase of MDD and is associated with residual clinical symptoms. These patterns may confer risk for future relapse or alternatively, support wellness.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27136416     DOI: 10.1016/j.jad.2016.03.059

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

1.  Developmental changes in resting-state functional networks among individuals with and without internalizing psychopathologies.

Authors:  Katie L Burkhouse; Jonathan P Stange; Rachel H Jacobs; Runa Bhaumik; Katie L Bessette; Amy T Peters; Natania A Crane; Kayla A Kreutzer; Kate Fitzgerald; Christopher S Monk; Robert C Welsh; K Luan Phan; Scott A Langenecker
Journal:  Depress Anxiety       Date:  2018-12-05       Impact factor: 6.505

2.  Pre-scan cortisol is differentially associated with enhanced connectivity to the cognitive control network in young adults with a history of depression.

Authors:  Amy T Peters; Lisanne M Jenkins; Jonathan P Stange; Katie L Bessette; Kristy A Skerrett; Leah R Kling; Robert C Welsh; Mohammed R Milad; Kinh L Phan; Scott A Langenecker
Journal:  Psychoneuroendocrinology       Date:  2019-03-12       Impact factor: 4.905

3.  Acute cortisol reactivity attenuates engagement of fronto-parietal and striatal regions during emotion processing in negative mood disorders.

Authors:  Amy T Peters; Anna Van Meter; Patrick J Pruitt; Emily M Briceño; Kelly A Ryan; Melissa Hagan; Anne L Weldon; Michelle T Kassel; Aaron Vederman; Jon-Kar Zubieta; Melvin McInnis; Sara L Weisenbach; Scott A Langenecker
Journal:  Psychoneuroendocrinology       Date:  2016-07-22       Impact factor: 4.905

4.  Emotion dysregulation and functional connectivity in children with and without a history of major depressive disorder.

Authors:  Katherine C Lopez; Joan L Luby; Andy C Belden; Deanna M Barch
Journal:  Cogn Affect Behav Neurosci       Date:  2018-04       Impact factor: 3.282

Review 5.  A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression.

Authors:  Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

6.  Hyperconnectivity between the posterior cingulate and middle frontal and temporal gyrus in depression: Based on functional connectivity meta-analyses.

Authors:  Ziqing Zhu; You Wang; Way K W Lau; Xinhua Wei; Yingjun Liu; Ruiwang Huang; Ruibin Zhang
Journal:  Brain Imaging Behav       Date:  2022-01-28       Impact factor: 3.224

7.  Regional cerebral metabolism alterations affect resting-state functional connectivity in major depressive disorder.

Authors:  Hui Su; Chuantao Zuo; Huiwei Zhang; Fangyang Jiao; Bin Zhang; Weijun Tang; Daoyin Geng; Yihui Guan; Shenxun Shi
Journal:  Quant Imaging Med Surg       Date:  2018-10

8.  Resting state functional connectivity correlates of rumination and worry in internalizing psychopathologies.

Authors:  Cope Feurer; Jagan Jimmy; Fini Chang; Scott A Langenecker; K Luan Phan; Olusola Ajilore; Heide Klumpp
Journal:  Depress Anxiety       Date:  2021-02-23       Impact factor: 6.505

Review 9.  Cognitive effects of rapid-acting treatments for resistant depression: Just adverse, or contributing to clinical efficacy?

Authors:  Salvador M Guinjoan; Karl-Jürgen Bär; Joan A Camprodon
Journal:  J Psychiatr Res       Date:  2021-06-15       Impact factor: 5.250

10.  Using Network Parcels and Resting-State Networks to Estimate Correlates of Mood Disorder and Related Research Domain Criteria Constructs of Reward Responsiveness and Inhibitory Control.

Authors:  Scott A Langenecker; Mindy Westlund Schreiner; Leah R Thomas; Katie L Bessette; Sophia R DelDonno; Lisanne M Jenkins; Rebecca E Easter; Jonathan P Stange; Stephanie L Pocius; Alina Dillahunt; Tiffany M Love; K Luan Phan; Vincent Koppelmans; Martin Paulus; Martin A Lindquist; Brian Caffo; Brian J Mickey; Robert C Welsh
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.